UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐...
Zhongchao Inc. Reports the Fiscal Year 2021 Financial Results PR Newswire SHANGHAI, May 9, 2022 SHANGHAI, May 9, 2022 /PRNewswire/ --Β Zhongchao...
Filed Pursuant to Rule 424(b)(5) Registration No. 333-256190 PROSPECTUS SUPPLEMENT (To Prospectus Dated...
Zhongchao Inc. Announces Its Patient Management System Improves Its Liver Cancer Patients' Duration of Therapy by 40%, Promoting Successful...
Zhongchao Inc. Launches Hematology MDT Training Platform to Improve Diagnosis and Treatment PR Newswire SHANGHAI, Sept. 17, 2021 SHANGHAI, Sept...
Zhongchao Inc. Announces Hematological Tumor Patient Management Business to Further Expand to Out-of-Hospital Market PR Newswire SHANGHAI, Sept...
Zhongchao Inc. Expands Patient Management Business to Ovarian Cancer Market PR Newswire SHANGHAI, Aug. 25, 2021 SHANGHAI, Aug. 25, 2021...
Zhongchao Inc. Builds A Patient DOT Management System PR Newswire SHANGHAI, China, Aug. 12, 2021 SHANGHAI, China, Aug. 12, 2021 /PRNewswire/...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form...
Zhongchao Inc. Builds A Platform for Breast Cancer Tiered Diagnosis and Treatment Improvement To Promote the Equalization of Breast Cancer...
Zhongchao Inc. Announces the Establishment of a New Subsidiary Ningxia Zhongxin Internet Hospital Co., Ltd. for Patient Management PR...
Zhongchao Inc. Partners with a Subsidiary of AbbVie Inc. (NYSE: ABBV) for Medical Education Services PR Newswire SHANGHAI, June 16, 2021...
Zhongchao Inc. Announces the On-Going One-Year Leukemia Education Project with Bethune Foundation and BeiGene Shanghai PR Newswire SHANGHAI, June...
Zhongchao Inc. Launched New Line of Business Focusing on Tumor and Rare Disease Patient Management PR Newswire SHANGHAI, May 28, 2021 SHANGHAI...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads